NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,172,612 | -3.8% | 11,512 | -4.7% | 0.11% | -1.7% |
Q2 2023 | $1,219,497 | +11.2% | 12,085 | +1.4% | 0.12% | +1.8% |
Q1 2023 | $1,096,272 | -2.4% | 11,916 | -3.8% | 0.11% | -6.6% |
Q4 2022 | $1,123,295 | +17.1% | 12,382 | -1.9% | 0.12% | +15.1% |
Q3 2022 | $959,000 | -11.1% | 12,619 | -1.1% | 0.11% | -5.4% |
Q2 2022 | $1,079,000 | -10.3% | 12,765 | -6.9% | 0.11% | +3.7% |
Q1 2022 | $1,203,000 | +3.4% | 13,707 | +3.1% | 0.11% | +4.9% |
Q4 2021 | $1,163,000 | +15.5% | 13,298 | +12.0% | 0.10% | +14.4% |
Q3 2021 | $1,007,000 | -1.8% | 11,872 | -1.1% | 0.09% | -26.8% |
Q1 2021 | $1,025,000 | -12.5% | 12,003 | -3.2% | 0.12% | -20.1% |
Q4 2020 | $1,171,000 | +14.0% | 12,397 | +5.0% | 0.15% | -17.6% |
Q3 2020 | $1,027,000 | +3.4% | 11,805 | +3.9% | 0.19% | -42.1% |
Q2 2020 | $993,000 | -15.3% | 11,366 | -19.7% | 0.32% | -8.2% |
Q1 2020 | $1,173,000 | -15.6% | 14,155 | -3.5% | 0.35% | -5.9% |
Q4 2019 | $1,389,000 | – | 14,673 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |